The relationship between the Glasgow Microenvironment Score and markers of epithelial-mesenchymal transition in TNM II-III colorectal cancer

Alexander, P. G. et al. (2022) The relationship between the Glasgow Microenvironment Score and markers of epithelial-mesenchymal transition in TNM II-III colorectal cancer. Human Pathology, 127, pp. 1-11. (doi: 10.1016/j.humpath.2022.05.012) (PMID:35623467)

[img] Text
276278.pdf - Published Version
Available under License Creative Commons Attribution.

1MB
[img] Text
276278Suppl.pdf - Supplemental Material

1MB

Abstract

Recently published work on the Glasgow Microenvironment Score (GMS) demonstrated its relevance as a biomarker in TNM II-III colorectal cancer (CRC). Epithelial-mesenchymal transition (EMT) markers in CRC have also shown promise as prognostic biomarkers. This study aimed to assess the relationship between GMS and markers of EMT in stage II-III CRC. A previously constructed tissue microarray of CRC tumors resected between 2000 and 2007 from the Western Infirmary, Stobhill, and Gartnavel General Hospitals in Glasgow was used. Immunohistochemistry was performed for 5 markers of EMT: E-cadherin, β-catenin, Fascin, Snail, and Zeb1. Two-hundred and thirty-eight TNM II-III CRC with valid scores for all EMT markers and GMS were assessed. The prognostic significance of markers of EMT in this cohort and relationships between GMS and markers of EMT were determined. High cytoplasmic and nuclear β-catenin and membrane Zeb-1 were significant for worse cancer-specific survival (hazard ratio [HR] 1.67, 95% confidence interval [CI] 1.01–2.76, P < .05; HR 2.22, 95% CI 1.24–3.97, P < .01; and HR 2.00, 95% CI 1.07–3.77, P = .03, respectively). GMS 0 was associated with low membrane Fascin (P = .03), whereas membrane and cytoplasmic Fascin were observed to be highest in GMS 1, but lower in GMS 2. Nuclear β-catenin was lowest in GMS 0, but highest in GMS 2 (P = .03), in keeping with its role in facilitating EMT. Novel associations were demonstrated between GMS categories and markers of EMT, particularly β-catenin and Fascin, which require further investigation in independent cohorts.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Park, Mr James and Horgan, Professor Paul and Roseweir, Dr Antonia and Matly, Mrs Amna and Pennel, Miss Kathryn and Roxburgh, Professor Campbell and Quinn, Dr Jean and Edwards, Professor Joanne and Jirapongwattana, Niphat and Alexander, Peter and McMillan, Professor Donald and Van Wyk, Dr Hester
Authors: Alexander, P. G., Matly, A. A.M., Jirapongwattana, N., Pennel, K. A.F., Van Wyk, H. C., McMillan, D. C., Horgan, P. G., Roxburgh, C. S.D., Thuwajit, C., Roseweir, A. K., Quinn, J., Park, J. H., and Edwards, J.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Human Pathology
Publisher:Elsevier
ISSN:0046-8177
ISSN (Online):1532-8392
Published Online:25 May 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Human Pathology 127: 1-11
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record